Cargando…

T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants

T cell responses are a key cornerstone to viral immunity to drive high-quality antibody responses, establishing memory for recall and for viral clearance. Inefficient recruitment of T cell responses plays a role in the development of severe COVID-19 and is also represented by reduced cellular respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Thi H. O., Cohen, Carolyn A., Rowntree, Louise C., Bull, Maireid B., Hachim, Asmaa, Kedzierska, Katherine, Valkenburg, Sophie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739267/ https://www.ncbi.nlm.nih.gov/pubmed/35004764 http://dx.doi.org/10.3389/fmed.2021.793102

Ejemplares similares

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
por: Hachim, Asmaa, et al.
Publicado: (2021)

Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread
por: Bull, Maireid B., et al.
Publicado: (2021)

Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue
por: Valkenburg, Sophie A., et al.
Publicado: (2021)

Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein
por: Chaurasia, Priyanka, et al.
Publicado: (2021)

Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses
por: Kavian, Niloufar, et al.
Publicado: (2021)

Next-generation T cell–activating vaccination increases influenza virus mutation prevalence
por: Bull, Maireid B., et al.
Publicado: (2022)

Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection
por: Kavian, Niloufar, et al.
Publicado: (2020)

SARS‐CoV‐2‐specific CD8(+) T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
por: Rowntree, Louise C, et al.
Publicado: (2021)

Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
por: Hachim, Asmaa, et al.
Publicado: (2020)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A, et al.
Publicado: (2021)

Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
por: Farr, Ryan J., et al.
Publicado: (2021)

The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
por: Valkenburg, Sophie A., et al.
Publicado: (2018)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A., et al.
Publicado: (2021)

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
por: Lau, Jonathan J., et al.
Publicado: (2023)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults
por: Kavian, Niloufar, et al.
Publicado: (2020)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
por: Smatti, Maria K., et al.
Publicado: (2022)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

SARS-CoV-2 variants: Impact on biological and clinical outcome
por: Mahilkar, Shakuntala, et al.
Publicado: (2022)

Characterizing the Severity of SARS-CoV-2 Variants at a Single Pediatric Center
por: Khan, Aslam, et al.
Publicado: (2022)

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
por: Mazzaferri, Fulvia, et al.
Publicado: (2022)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
por: Li, Qinggang, et al.
Publicado: (2022)

Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China
por: Cheng, Xiao-wen, et al.
Publicado: (2022)

The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
por: Akkız, Hikmet
Publicado: (2022)

Universal immunity to influenza must outwit immune evasion
por: Quiñones-Parra, Sergio, et al.
Publicado: (2014)

Use it or lose it: establishment and persistence of T cell memory
por: Kedzierska, Katherine, et al.
Publicado: (2012)

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
por: Koutsakos, Marios, et al.
Publicado: (2023)

Growth, Antigenicity, and Immunogenicity of SARS-CoV-2 Spike Variants Revealed by a Live rVSV-SARS-CoV-2 Virus
por: Ding, Limin S., et al.
Publicado: (2022)

Epidemiological Dynamics of SARS-CoV-2 Variants During Social Protests in Cali, Colombia
por: Patiño, Luz H., et al.
Publicado: (2022)

Count on us: T cells in SARS-CoV-2 infection and vaccination
por: Kedzierska, Katherine, et al.
Publicado: (2022)

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2020)

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2021)

Commentary: Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
por: Haddadi, Sara, et al.
Publicado: (2021)

Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?
por: Gunadi,, et al.
Publicado: (2021)

Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?
por: Rodriguez-Sevilla, Juan Jose, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
por: Zhang, Jianguo, et al.
Publicado: (2022)

Challenges and Issues of Anti-SARS-CoV-2 Vaccines
por: Blumental, Sophie, et al.
Publicado: (2021)

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
por: Hachim, Asmaa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9qb4vphf69kdjh3r21fnuajc5b